Dirk L. Kienle
Chur, GR, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
Journal: Blood advances
Published: November 02, 2021
Approved and emerging PI3K inhibitors for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Journal: Expert opinion on pharmacotherapy
Published: March 13, 2020
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10.
Journal: Journal of geriatric oncology
Published: June 27, 2018
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 09, 2016
The spleen in hematologic malignancies
Journal: Therapeutische Umschau. Revue therapeutique
Published: March 05, 2013
BRAF mutations in chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: October 24, 2012
Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 24, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026